AI-generated summary
The authors report a randomized controlled trial in which 42 older women with mild cognitive impairment received five sessions of 850 nm transcranial photobiomodulation or sham treatment. Compared with the sham group, the real treatment group showed improvements on a cognitive screening test and on attention measures. The authors conclude the treatment had a positive effect, but the abstract provides limited detail on the design.
- Participants
- 42
- Who or what was studied
- Older women with mild cognitive impairment
- Wavelengths
- 850 nm
- Limits stated in the abstract
- The abstract reports a small sample of 42 women split into two groups and does not describe a long-term follow-up or a placebo-blinding method.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on termedia.pl.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Transcranial photobiomodulation, Mild cognitive impairment, Randomized controlled trial, Photobiomodulation, Neuromodulation, Near-infrared, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.